Different effects of atrial and C-type natriuretic peptide on the urinary excretion of endothelin-1 in man

Clinical Science

Volumn 95, Issue 5, 1998, Pages 595-602

  La Villa, Giorgio ^a   Mannelli, Massimo ^a   Lazzeri, Chiara ^a   Vecchiarino, Sabrina ^a   De Feo, Maria Laura ^a   Tosti Guerra, Cristina ^a   Bandinelli, Renzo ^b   Foschi, Marco ^a   Franchi, Franco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Atrial natriuretic peptide; C type natriuretic peptide; Endothelin; Kidney; Natriuretic peptide receptor

Indexed keywords

4 AMINOHIPPURIC ACID; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATININE; CYCLIC GMP; ENDOTHELIN 1; GUANYLATE CYCLASE; NATRIURETIC PEPTIDE RECEPTOR; NATRIURETIC PEPTIDE TYPE C; RECEPTOR; UNCLASSIFIED DRUG;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; ENZYME ACTIVATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; KIDNEY PLASMA FLOW; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SODIUM BLOOD LEVEL; SODIUM EXCRETION; URINARY EXCRETION; URINE FLOW RATE;

EID: 0031771214     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS19970264     Document Type: Article

References (52)

1. Lewicki, J. A. and Protter, A. A. (1995) Physiological studies of the natriuretic peptide family. In Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn (Laragh, J. H. and Brenner, B. M., eds.), pp. 1029-1053, Raven Press, New York
2. Brenner, B. M., Ballermann, M. E., Gunning, E. and Zeidel, M. L. (1990) Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70, 655-699
3. Lang, C. C, Choy, A. M. J. and Struthers, A. D. (1992) Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homoeostasis. Clin. Sci. 83, 519-527
4. Gunning, M. E., Ingelfinger, J. R., King, A. J. and Brenner, B. M. (1996) Vasoactive peptides and the kidney. In Brenner and Rector's The Kidney (Brenner, B. M., ed.), pp. 627-712, Saunders, Philadelphia
5. Sudoh, T., Minamino, N., Kangawa, K. and Matsuo, H. (1990) C-type natriuretic peptide (CNP): a new member of the natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168, 863-870
6. Stingo, A. J., Clavell, A. L., Heublein, D. M., Wei, C. M., Pittelkow, M. R. and Burnett, Jr., J. C. (1992) Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am. J. Physiol. 263, H1318-H1321
7. Hunt, P. J., Richards, A. M., Espiner, E. A., Nicholls, M. G. and Yandle, T. G. (1994) Bioactivity and metabolism of C-type natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 78, 1428-1435
8. Pham, I., Sesiame, S., Maistre, G. et al. (1997) Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Am. J. Physiol. 273, R1457-R1464
9. Gunning, M. and Brenner, B. M. (1995) Urodilatin. In Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn (Laragh, J. H. and Brenner, B. M., eds.), pp. 1021-1027, Raven Press, New York
10. Suga, S., Nakao, K., Hosoda, K. et al. (1992) Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology (Baltimore) 130, 229-239
11. Levin, E. R. (1993) Natriuretic peptide C-receptor: more than a clearance receptor. Am. J. Physiol. 264, E483-E489
12. De Feo, M. L., La Villa, G., Lazzeri, C. et al. (1997) Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans. Hypertension 29, 70-74
13. La Villa, G., Fronzaroli, C., Lazzeri, C. et al. (1994) Cardiovascular and renal effects of low-dose brain natriuretic peptide infusion in man. J. Clin. Endocrinol. Metab. 78, 1166-1171
14. Burnett, Jr., C., Kao, P. C., Hu, D. C. et al. (1986) Atrial natriuretic peptide elevation in congestive heart failure in the human. Science (Washington DC) 231, 1145-1147
15. Pearson, E. S. and Hartley, H. O. (1951) Chart for the power function for analysis of variance tests, derived from the noncentral F distribution. Biometrika 38, 112-130
16. Yanagisawa, M., Kurihara, H., Kimura, S. et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London) 332, 411-415
17. Simonson, M. S. (1993) Endothelins: multifunctional renal peptides. Physiol. Rev. 73, 375-411
18. Pupilli, C., Brunori, M., Misciglia, N. et al. (1994) Presence and distribution of endothelin-1 gene expression in human kidney. Am. J. Physiol. 267, F679-F687
19. Wilkes, B. M., Susin, M., Mento, P. F. et al. (1991) Localization of endothelin-like immunoreactivity in rat kidneys. Am. J. Physiol. 260, F913-F920
20. Abassi, Z. A., Tate, J. E., Golomb, E. and Keiser, H. R. (1992) Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 20, 89-95
21. Modesti, P. A., Cecioni, I., Naldoni, A., Migliorini, A. and Neri Serneri, G. G. (1996) Relationship of renin-angiotensin system and ET-1 system activation in long-lasting response to postural changes. Am. J. Physiol. 270, H1200-H1206
22. Neri Serneri, G. G., Modesti, P. A., Cecioni, I. et al. (1995) Plasma endothelin and renal endothelin are two distinct systems involved in volume homeostasis. Am. J. Physiol. 268, H1829-H1837
23. Bruneau, B. G. and de Bold, A. J. (1994) Selective changes in natriuretic peptide and early response gene expression in isolated rat atria following stimulation by stretch or endothelin-1. Cardiovasc. Res. 28, 1519-1525
24. Goetz, K. L., Wang, B. C., Madwed, J. B., Zhu, L. J. and Leadley, Jr., R. J. (1988) Cardiovascular, renal and endocrine responses to intravenous endothelin in conscious dogs. Am. J. Physiol. 255, R1064-R1068
25. Ota, K., Kimura, T., Shoji, M. et al. (1992) Interactions of ANP with endothelin on cardiovascular, renal, and endocrine functions. Am. J. Physiol. 262, E135-E141
26. Saijonmaa, O., Ristimaki, A. and Fyhrquist, F. (1990) Atrial natriuretic peptide, nitroglycerine and nitroprussate reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem. Biophys. Res. Commun. 173, 514-520
27. Kohno, M., Horio, T., Ikeda, M. et al. (1993) Natriuretic peptides inhibit mesangial cell production of endothelin induced by arginine vasopressin. Am. J. Physiol. 264, F678-F683
28. Clavell, A. L., Stingo, A. J., Margulies, K. B., Brandt, R. R. and Burnett, Jr., J. C. (1995) Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am. J. Physiol. 268, F455-F460
29. Sandgaard, N. C. and Bie, P. (1996) Natriuretic effect of non-pressor doses of endothelin-1 in conscious dogs. J. Physiol. (London) 494, 809-818
30. Kohno, M., Yasunari, K., Yokokawa, K., Murakawa, K., Horio, T. and Takeda, T. (1991) Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J. Clin. Invest. 87, 1999-2004
31. Ando, S., Rahman, M. A., Butler, G. C., Senn, B. L. and Floras, J. S. (1995) Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin. Hypertension 26, 1160-1166
32. Worgall, S., Manz, F., Kleschin, K., Feth, F. and Rascher, W. (1994) Elevated urinary excretion of endothelin-like immunoreactivity in children with renal disease is related to urine flow rate. Clin. Nephrol. 41, 331-337
33. Zeiler, M., Löffler, B. M., Bock, H. A. and Thiel, G. (1995) ET-1 excretion is urine flow-dependent in kidney donors and transplant recipients. J. Cardiovasc. Pharmacol. 26 (Suppl. 3), S513-S515
34. De Feo, M. L., Bartolini O., Orlando C. et al. (1991) Natriuretic peptide receptors regulate endothelin synthesis and release from parathyroid cells. Proc. Natl. Acad. Sci. U.S.A. 88, 6496-6500
35. Marin-Grez, M., Fleming, J. T. and Steinhausen, M. (1986) Atrial natriuretic peptide causes pre-glomerular vasodilation and post-glomerular vasoconstriction in rat kidney (Letter). Nature (London) 324, 473-476
36. Lanese, D. M., Yuan, B. H., Falk, S. A. and Conger, J. D. (1991) Effects of atriopeptin III on isolated rat afferent and efferent arterioles. Am. J. Physiol. 261, F1102-F1109
37. Dunn, B. R., Ichikawa, I., Pfeffer, J. M., Troy, J. L. and Brenner, B. M. (1986) Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anesthetized rat. Circ. Res. 59, 237-246
38. McMurray, J., Seidelin, P. H., Howey, J. E., Balfour, D. J. and Struthers, A. D. (1988) The effects of atrial natriuretic factor on urinary albumin and beta 2-microglobulin excretion in man. J. Hypertens. 6, 783-786
39. Eiskjaer, H., Mogensen, C. E., Schmitz, A. and Pedersen, E. B. (1991) Enhanced urinary excretion of albumin and beta 2-microglobulin in essential hypertension induced by atrial natriuretic peptide. Scand. J. Lab. Invest. 51, 359-366
40. Ishi, M., Hirata, Y., Sugimoto, T. et al. (1989) Effect of α-human atrial natriuretic peptide on proteinuria in patients with primary glomerular diseases. Clin. Sci. 77, 643-650
41. Zietse, R., Derkx, F. H., Weimar, W. and Shalekamp, M. A. (1995) Effects of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus. J. Am. Soc. Nephrol. 5, 2057-2066
42. Zoja, C., Morigi, M., Figliuzzi, M. et al. (1995) Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am. J. Kidney Dis. 26, 934-941
43. Bruzzi, I., Corna, D., Zoja, C. et al. (1997) Time course and localization of endothelin-1 gene expression in a model of renal disease progression. Am. J. Pathol. 151, 1241-1247
44. Patek, K. P. and Zhang, P. L. (1990) Attenuated renal responses to atrial natriuretic factor in streptozotocin-induced diabetic rats. Can. J. Physiol. Pharmacol. 68, 425-430
45. Sechi, L. A., Valentin, J. P., Griffin, C. A. et al. (1995) Receptors for atrial natriuretic pcptidc are decreased in the kidney of rats with streptozotocin-induced diabetes mcllitus. J. Clin. Invest. 95, 2451-2457
46. Lieberman, J. S., Parra, L., Newton, L., Scandling, J. D., Loon, N. and Myers, B. D. (1991) Atrial natriuretic peptide and response to changing plasma volume in diabetic nephropathy. Diabetes 40, 893-901
47. Morabito, E., Corsico, N., Serafini, S. and Martelli, E. A. (1994) Elevated urinary excretion of endothelins in streptozotocin diabetic rats. Life Sci. 54, PL13-PL18
48. Shin, S. J., Lee, Y. J. and Tsai, J. H. (1996) The correlation of plasma and urine endothelin-1 with the severity of nephropathy in Chinese patients with type 2 diabetes. Scand. J. Lab. Invest. 56, 571-576
49. Mattyus, I., Zimmerhackl, L. B., Schwarz, A., Brandis, M., Miltenyi, M. and Tulassay, T. (1996) Elevated urinary excretion of endothelin in insulin-dependent diabetes mellitus: no influence of physical exercise. Acta Paediatr. 85, 1058-1061
50. Richards, A. M., Nicholls, M. G., Espiner, E. A. et al. (1985) Effects of α-human atrial natriuretic peptide in essential hypertension. Hypertension 7, 812-817
51. Richards, A. M., Espiner, E. A., Ikram, H. and Yandle, T. G. (1989) Atrial natriuretic factor in hypertension: bioactivity at normal plasma levels. Hypertension 14, 261-268
52. Hoffman, A., Grossman, E., Goldstein, D. S., Gill, Jr., J. R. and Keiser, H. R. (1994) Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. Kidney Int. 45, 556-560